NPR: In a highly anticipated decision, the Food and Drug Administration authorized the first antiviral pill to treat COVID-19 at home.
The pill, called Paxlovid, is made by Pfizer. It’s taken twice a day for five days in combination with a second medicine called ritonavir, a generic antiviral.
Breaking News: The FDA has cleared Pfizer’s Covid pill, the first of its kind, for high-risk people 12 and over. It was found to protect against severe illness after infection. https://t.co/1JQ3XHSKD8
— The New York Times (@nytimes) December 22, 2021
“Today’s authorization introduces the first treatment for COVID-19 that is in the form of a pill that is taken orally — a major step forward in the fight against this global pandemic,” said Dr. Patrizia Cavazzoni, director of the FDA’s Center for Drug Evaluation and Research. “This authorization provides a new tool to combat COVID-19 at a crucial time in the pandemic as new variants emerge and promises to make antiviral treatment more accessible to patients who are at high risk for progression to severe COVID-19.”
Pfizer’s COVID-19 vaccine: “It is dystopian for the government to give Pfizer billions, mandate Americans to take its product, prohibit Americans from suing for harm, but yet refuse to let Americans see the data underlying its licensure.” https://t.co/rwrUbCnOMK
— Prof. Peter C Gøtzsche (@PGtzsche1) December 21, 2021
The Pfizer treatment could help keep people infected with the coronavirus from getting so sick that they need to be hospitalized.
The results from a Pfizer study involving more than 2,200 people at high risk for developing serious COVID-19 found Paxlovid reduced the risk of hospitalization or death by 89%, compared with a placebo, when taken within three days of first symptoms of illness. When taken within five days, the drug reduced the risk of hospitalization and death by 88%. Read more…